Immuno Oncology Assays Market Growth Analysis By Major Players Thermo Fischer scientific, HTG Molecular Diagnostics

The immuno-oncology assays are valuable tools in the fight against cancer. These newest methods help to determine how new drugs will interact with existing products and agents, researchers and doctors can design preventative drug plans and better target the treatment of malignant tumors. These assays have been developed to measure the ability of tumor cells to resist various viruses, bacteria, chemicals, and pesticides. These assays are important for both research and pre-clinical development of vaccines, medicines, and drugs.

Request Here PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2632

The rising prevalence of cancer around the globe is a prime factor driving the growth of the immuno oncology assays market. According to the World Health Organization, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. The immuno-oncology assay is widely used in clinical trials because it helps in reducing the cost of research and also improves the efficiency of therapies. Additionally, these assays enable easy understanding of the compound’s response intended to mimic the tumor microenvironment. Furthermore, these assays offer important information to confirm the efficiency of a drug and also provide easier & faster analysis of cancer. This is further anticipated to foster the growth of the immuno oncology assays market.

North America is expected to gain significant growth over the forecast period and this is attributed to the increased spending by the government on the research and development for developing novel drugs and biomarkers. According to the 7 American Medical Association, a recent estimate of cancer drug R&D spending was $2.7 billion (2017 US dollars). Also, the presence of strong players in the region such as Thermo Fisher and Illumina, Inc that are highly engaged in the clinical trials activities is further anticipated to foster the regional market growth.

Key Developments:

In February 2020, Biocare Medical, a provider of innovative, automated immunohistochemistry (IHC) reagents and instrumentation, announced the launch of seven novel IVD IHC antibody markers for clinical diagnostics and research applications.

In December 2019, 2cureX AB announced that the company presented significant progression of the IndiTreat® test for individualizing immuno-oncological treatment at the ESMO IO Congress.

In November 2019, QIAGEN announced a series of agreements that expand its immuno-oncology assets for future commercialization of novel companion diagnostics for precision medicine in immuno-oncology, in particular, based on the powerful next-generation sequencing (NGS) technology.

Request for a Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/2632

Major Players Are Operating In This Market Are: Roche Diagnostics, Agilent Technologies, Qiagen, Merck, Thermo Fischer scientific, HTG Molecular Diagnostics, Perkinelmer, Sartorius AG, and lllumina, Merck, Perkinelmer.

Highlights of the Immuno Oncology Assays report:

1. A complete backdrop analysis, which includes an assessment of the Immuno Oncology Assays Market
2. An objective assessment of the trajectory of the market
3. Market segmentation up to the second or third level
4. Reporting and evaluation of recent industry developments
5. Important changes in market dynamics
6. Emerging niche segments and regional markets
7. Historical, current, and projected size of the market from the standpoint of both value and volume
8. Market shares and strategies of key players
9. Recommendations to companies for strengthening their foothold in the market

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.